These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18980247)

  • 21. CDK11p58 represses vitamin D receptor-mediated transcriptional activation through promoting its ubiquitin-proteasome degradation.
    Chi Y; Hong Y; Zong H; Wang Y; Zou W; Yang J; Kong X; Yun X; Gu J
    Biochem Biophys Res Commun; 2009 Aug; 386(3):493-8. PubMed ID: 19538938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heavy chain of cytoplasmic dynein is a major component of the postsynaptic density fraction.
    Cheng HH; Liu SH; Lee HC; Lin YS; Huang ZH; Hsu CI; Chen YC; Chang YC
    J Neurosci Res; 2006 Aug; 84(2):244-54. PubMed ID: 16721762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRMP-2 directly binds to cytoplasmic dynein and interferes with its activity.
    Arimura N; Hattori A; Kimura T; Nakamuta S; Funahashi Y; Hirotsune S; Furuta K; Urano T; Toyoshima YY; Kaibuchi K
    J Neurochem; 2009 Oct; 111(2):380-90. PubMed ID: 19659462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation.
    Burrows JF; McGrattan MJ; Rascle A; Humbert M; Baek KH; Johnston JA
    J Biol Chem; 2004 Apr; 279(14):13993-4000. PubMed ID: 14699124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DUBs and disease: activity assays for inhibitor development.
    Shanmugham A; Ovaa H
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):688-96. PubMed ID: 18729020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zinc-finger UBPs: regulators of deubiquitylation.
    Bonnet J; Romier C; Tora L; Devys D
    Trends Biochem Sci; 2008 Aug; 33(8):369-75. PubMed ID: 18603431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DUB-1, a deubiquitinating enzyme with growth-suppressing activity.
    Zhu Y; Carroll M; Papa FR; Hochstrasser M; D'Andrea AD
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3275-9. PubMed ID: 8622927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural aspects of recently discovered viral deubiquitinating activities.
    Sulea T; Lindner HA; Ménard R
    Biol Chem; 2006 Jul; 387(7):853-62. PubMed ID: 16913834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anchoring of the 26S proteasome to the organellar membrane by FKBP38.
    Nakagawa T; Shirane M; Iemura S; Natsume T; Nakayama KI
    Genes Cells; 2007 Jun; 12(6):709-19. PubMed ID: 17573772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Navigating the deubiquitinating proteome with a CompPASS.
    Jackson PK
    Cell; 2009 Jul; 138(2):222-4. PubMed ID: 19632171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-Translational Modifications of Extracellular Proteasome.
    Tsimokha AS; Artamonova TO; Diakonov EE; Khodorkovskii MA; Tomilin AN
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32752045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The ubiquitin-like protein monoclonal nonspecific suppressor factor beta conjugates to endophilin II and regulates phagocytosis.
    Nakamura M; Shimosaki S
    FEBS J; 2009 Nov; 276(21):6355-63. PubMed ID: 19796172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conjugation of complex polyubiquitin chains to WRNIP1.
    Bish RA; Fregoso OI; Piccini A; Myers MP
    J Proteome Res; 2008 Aug; 7(8):3481-9. PubMed ID: 18613717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The vital link between the ubiquitin-proteasome pathway and DNA repair: impact on cancer therapy.
    Motegi A; Murakawa Y; Takeda S
    Cancer Lett; 2009 Sep; 283(1):1-9. PubMed ID: 19201084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dysfunction of the ubiquitin-proteasome system in multiple disease conditions: therapeutic approaches.
    Paul S
    Bioessays; 2008 Nov; 30(11-12):1172-84. PubMed ID: 18937370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deubiquitylases from genes to organism.
    Clague MJ; Barsukov I; Coulson JM; Liu H; Rigden DJ; Urbé S
    Physiol Rev; 2013 Jul; 93(3):1289-315. PubMed ID: 23899565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell-cycle-dependent PC-PLC regulation by APC/C(Cdc20)-mediated ubiquitin-proteasome pathway.
    Fu D; Ma Y; Wu W; Zhu X; Jia C; Zhao Q; Zhang C; Wu XZ
    J Cell Biochem; 2009 Jul; 107(4):686-96. PubMed ID: 19347873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The proteasomal system.
    Jung T; Catalgol B; Grune T
    Mol Aspects Med; 2009 Aug; 30(4):191-296. PubMed ID: 19371762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strategies for assaying deubiquitinating enzymes.
    Kang SH; Park JJ; Chung SS; Bang OS; Chung CH
    Methods Enzymol; 2005; 398():500-8. PubMed ID: 16275354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Profiling of transcripts and proteins modulated by K-ras oncogene in the lung tissues of K-ras transgenic mice by omics approaches.
    Lee S; Kang J; Cho M; Seo E; Choi H; Kim E; Kim J; Kim H; Kang GY; Kim KP; Park YH; Yu DY; Yum YN; Park SN; Yoon DY
    Int J Oncol; 2009 Jan; 34(1):161-72. PubMed ID: 19082487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.